7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Dr. Yasemin Ersoy Clinical Laboratory · Acibadem Kayseri Hospital

Prof. Dr. Yasemin Ersoy

✓ Medically verified profile
Clinical Laboratory · Acibadem Kayseri Hospital

Prof. Dr. Yasemin Ersoy

Prof. Dr. Yasemin Ersoy is a Clinical Laboratory specialist in Infectious Diseases and Clinical Microbiology at Acibadem Kayseri Hospital in Kayseri. She evaluates and treats lower respiratory tract infections including bronchitis and pneumonia, communicable and sexually transmitted infections such as syphilis, hepatitis, HIV and AIDS and HPV, and shingles, and provides adult vaccination. She consults in Turkish and English.

Medically verified profile 34+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Ersoy Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Dr. Yasemin ErsoyAccepting international patients
SpecialtyClinical Laboratory
ConsultationVideo · In person · Second opinion
Profile

About Prof. Dr. Yasemin Ersoy

Prof. Dr. Yasemin Ersoy is a Clinical Laboratory specialist with a subspecialty in Infectious Diseases and Clinical Microbiology. She practices at Acibadem Kayseri Hospital in Kayseri, where she works in the Clinical Laboratory and Infectious Diseases and Clinical Microbiology units. Dr. Ersoy has more than 34 years in medicine, most of them spent in academic infectious diseases practice, and she joined Acıbadem Healthcare Services in 2024.

She graduated from Erciyes University Faculty of Medicine in 1992 and completed her specialization in Infectious Diseases and Clinical Microbiology at İnönü University Faculty of Medicine in 2000. Her academic career developed at the same institution, in the Department of Infectious Diseases and Clinical Microbiology within the Department of Internal Medicine at İnönü University Faculty of Medicine, where she served as research assistant (1995–2000), lecturer (2000–2001), assistant professor (2001–2006), associate professor (2006–2011) and professor (2011–2024). Dr. Ersoy is a member of the Hospital Infections Association, the Clinical Microbiology and Infectious Diseases Association (KLİMİK), the Turkish Infectious Diseases and Clinical Microbiology Specialty Association (EKMUD) and the Sepsis Çalışma Grubu-EKMUD. Her published work includes studies on the CD4/CD8 ratio in the treatment follow-up of patients with HIV, angiotensin II and angiotensin II receptor 2 levels in septic patients, bloodstream infections in critically ill COVID-19 patients (Eurobact II study), oral colonization of Acinetobacter baumannii in intensive care units, viral and atypical pathogens in patients with pneumonia, and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in urinary tract infections.

Clinical focus

Dr. Ersoy evaluates and treats adults with infectious conditions, combining clinical assessment with laboratory-based diagnostics. Her areas of expertise include lower respiratory tract infections such as bronchitis and pneumonia, as well as communicable diseases more broadly. She also sees patients with sexually transmitted infections, including syphilis, HIV and AIDS, and HPV, and patients with hepatitis.

A further part of her practice is preventive care, in particular adult vaccination, together with the assessment and management of shingles. Where appropriate, microbiological and laboratory testing is used to help identify the pathogen and to inform treatment decisions, and follow-up may include repeat laboratory monitoring depending on the condition.

How Dr. Ersoy works with international patients

Dr. Ersoy consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, for example laboratory and pathology results, X-ray, CT or ultrasound reports, operative notes and discharge summaries, and arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients.

Clinical focus

What Dr. Ersoy treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Areas of practiceInfectious diseases and clinical microbiology

Conditions treated

Background

Education, career and memberships

Education & training

Education

  • 2000İnönü University Faculty of Medicine Infectious Diseases and Clinical Microbiology
  • 1992Erciyes University Faculty of Medicine
Career

Professional Experience

  • 2024Acıbadem Healthcare Services
  • 2011–2024İnönü University / Faculty of Medicine / Department of Internal Medicine / Department of Infectious Diseases and Clinical Microbiology / Professor, MD
  • 2006–2011İnönü University / Faculty of Medicine / Department of Internal Medicine / Department of Infectious Diseases and Clinical Microbiology / Associate Professor, MD
  • 2001–2006İnönü University / Faculty of Medicine / Department of Internal Medicine / Department of Infectious Diseases and Clinical Microbiology / Assistant Professor, MD
  • 2000–2001İnönü University / Faculty of Medicine / Department of Internal Medicine / Department of Infectious Diseases and Clinical Microbiology / Lecturer
  • 1995–2000İnönü University / Faculty of Medicine / Department of Internal Medicine / Department of Infectious Diseases and Clinical Microbiology / Research Assistant
Memberships

Professional Memberships

  • Hospital Infections Association
  • Clinical Microbiology and Infectious Diseases Association (KLİMİK)
  • Turkish Infectious Diseases and Clinical Microbiology Specialty Association (EKMUD)
  • Turkish Infectious Diseases and Clinical Microbiology Specialty Association (EKMUD)
  • Sepsis Çalışma Grubu-EKMUD
Selected publications

Selected Publications

  • Evaluation of CD4/CD8 ratio in treatment follow-up of patients with HIV diagnois in an infection clinic Annals of Medicial Research, 29(7), 743-747., Doi: 10.5455/annalsmedres.2022.01.022 (Publication No: 8104187) GEZER YAKUP, ALTUNIŞIK TOPLU SİBEL, YÜKSEL MUSTAFA, KÖSE ADEM, MEMİŞOĞLU FUNDA, ÖZDEN MEHMET, BAYINDIR YAŞAR, ERSOY YASEMİN
  • Angiotensin II and angiotensin II receptor 2 levels can predict shock and mortality in septic patients Minerva Anestesiologica, 88(12), 1021-1029., Doi: 10.23736/S0375-9393.22.16566-1 (Publication No: 8117660) (2022) ÖZER AYŞE BELİN, BIÇAKCIOĞLU MURAT, BAYKAN ŞEYMA, BULUT NİLÜFER, KALKAN SERKAN SERKAN, DEMİRCAN SELÇUK, KORKMAZ DİŞLİ ZELİHA, DÜZENCİ DECCANE, AYDOĞAN MUS
  • Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock Minerva Anestesiologica, Doi: 10.23736/S0375-9393.22.16766-0 (Publication No: 8104083) (2022) BAYKAN ŞEYMA, BIÇAKCIOĞLU MURAT, BULUT NİLÜFER, YÜCEL NESLİHAN, ERSOY YASEMİN, KIBRISLIOĞLU NERMİN, ÖZER AYŞE BELİN
  • Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study Critical Care, 26(319), 1-12., Doi: 10.1186/s13054-022-04166-y (Publication No: 8150882) (2022) ERSOY YASEMİN
  • Oral colonization of Acinetobacter baumannii in intensive care units: Risk factors, incidence, molecular epidemiology, association with the occurrence of pneumonia and sepsis, and infection control measures Iran J Basic Med Sci, 25(2), 239-244., Doi: 10.22038/IJBMS.2022.59713.13243 (Publication No: 8116112) DUMAN YÜCEL, ERSOY YASEMİN, TANRİVERDİ ELİF SEREN, OTLU BARIŞ, ALTUNIŞIK TOPLU SİBEL, GÖZÜKARA BAĞ HARİKA GÖZDE, TEKEREKOĞLU MEHMET SAİT, BULAM
  • Investigation of Viral and Atypical Pathogens in Patients with Pneumonia Who Need Intensive Care Unit. Flora Journal of Infectious Diseases and Clinical Microbiology, 27(1), Doi: 10.5578/flora.20229903 (Publication No: 8103841) (2022) DOĞAN AHMET, OTLU BARIŞ, ERSOY YASEMİN
  • Investigation of SARS-CoV-2 RNA in milk produced by women with COVID-19 and follow-up of their infants: A preliminary study. International Journal of Clinical Practice, 75, 1-7., Doi: 10.1111/ijcp.14175 (Publication No: 7379043) KILIÇ TALAT, KILIÇ ŞEBNEM, KIRICI BERBER NURCAN, GÜNDÜZ AYTEN, ERSOY YASEMİN
  • Antimicrobial susceptibility pattern of Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections in a tertiary care hospital. Annals of Medical Research, 28(7), 1406-1410., Doi: 10.5455/annalsmedres.2021.02.172 (Publication No: 7198154) DOĞAN AHMET, KÖSE ADEM, GEZER YAKUP, ERSOY YASEMİN, BAYINDIR YAŞAR, ÖZDEN MEHMET, MEMİŞOĞLU FUNDA, ALTUNIŞIK TOPLU SİBEL
  • The safety profile of favipiravir in COVID-19 patients with severe renal impairment International Journal of Clinical Practice, 75, 14938, Doi: 10.1111/ijcp.14938 (Publication No: 7240756) GÖK SELIM, BAHÇECİOĞLU ÖMER FARUK, DURMUŞ MEFKÜRE, GÜN ZEYNEP ÜLKÜ, ERSOY YASEMİN, AYTEMUR ZEYNEP AYFER, ULUTAŞ ÖZKAN
  • The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/ Mycobacterium tuberculosis exposure history in healthcare workers: a multi-center study Pathogens and Global Health, 115(6), 405-411., Doi: 10.1080/20477724.2021.1927605 (Publication No: 7474446) TORUN ŞERİFE, ÖZKAYA ŞEVKET, ŞEN NAZAN, KANAT FİKRET, KARAMAN İREM, YOSUNKAYA ŞEBNEM, ŞENGÖREN DİKİŞ ÖZLEM, ASAN ALİ, AYDOĞAN EROĞLU SELMA, ATAL SE
Good to Know

Frequently Asked Questions

Which infectious conditions does Dr. Ersoy evaluate and treat?
Dr. Ersoy's areas of expertise include lower respiratory tract infections such as bronchitis and pneumonia, communicable diseases, sexually transmitted infections including syphilis, HIV and AIDS and HPV, hepatitis, and shingles. She also provides adult vaccination. The suitability of any assessment or treatment is decided individually after a clinical evaluation.
Where does Dr. Ersoy see patients?
Dr. Ersoy practices at Acibadem Kayseri Hospital in Kayseri, where she works in the Clinical Laboratory and Infectious Diseases and Clinical Microbiology units. She joined Acıbadem Healthcare Services in 2024 after an academic career at İnönü University Faculty of Medicine.
Which languages can I use when consulting Dr. Ersoy?
Dr. Ersoy consults in Turkish and English. For patients who speak other languages, interpreters can be arranged through the international patient team, so that the consultation, the review of documents and the discussion of options can take place in a language the patient understands.
What should I send for a case review before my appointment?
It is helpful to provide existing laboratory and pathology results, imaging reports such as X-ray, CT or ultrasound, discharge summaries, operative notes and a summary of previous treatments. The international patient team coordinates the collection of these documents and arranges the appointment; a first consultation includes a review of this material.
What is Dr. Ersoy's training and academic background?
She graduated from Erciyes University Faculty of Medicine in 1992 and completed her specialization in Infectious Diseases and Clinical Microbiology at İnönü University Faculty of Medicine in 2000. At İnönü University she progressed from research assistant to professor, serving as Professor from 2011 to 2024. She is a member of KLİMİK, EKMUD and the Hospital Infections Association.
Can I have a video consultation with Dr. Ersoy from abroad?
Yes, video consultation is available for international patients. It can be used to discuss the patient's history and symptoms and to review existing reports and previous treatments. Whether an in-person visit, clinical examination or additional laboratory testing is needed is decided individually after this initial review.
Where

Hospitals

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.